Telomerase as a new target for pancreatic cancer treatment

Journal of Hepato-Biliary-Pancreatic Surgery

Volumn 9, Issue 3, 2002, Pages 322-327

  Sato, Norihiro ^a   Mizumoto, Kazuhiro ^a   Nagai, Eishi ^a   Tanaka, Masao ^a  

^a DEPARTMENT OF PATHOLOGY   (United States)

Author keywords

Chemosensitivity; Pancreatic cancer; Telomerase inhibitor

Indexed keywords

DNA; TELOMERASE; TELOMERASE INHIBITOR;

APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER RESEARCH; CARCINOGENESIS; CELL AGING; CELL DIVISION; CELL INVASION; CELL MIGRATION; CELL PROLIFERATION; CELL PROTECTION; CORRELATION ANALYSIS; DNA DAMAGE; DRUG TARGETING; ENZYME ACTIVITY; GROWTH INHIBITION; HUMAN; IN VITRO STUDY; IN VIVO STUDY; PANCREAS CANCER; PROTEIN EXPRESSION; TUMOR CELL;

ADENOCARCINOMA; ANTINEOPLASTIC AGENTS; CELL DEATH; CELL DIVISION; DNA-BINDING PROTEINS; ENZYME INHIBITORS; HUMANS; NEOPLASM INVASIVENESS; NEOPLASM METASTASIS; PANCREATIC NEOPLASMS; TELOMERASE;

EID: 0036041413     PISSN: 09441166     EISSN: None     Source Type: Journal    
DOI: 10.1007/s005340200036     Document Type: Article

References (79)

1. Cancer statistics, 2000
2. Pancreatic cancer: A report of treatment and survival trends for 100313 patients diagnosed from 1985-1995, using the National Cancer Database
3. The human telomere terminal transferase enzyme is a ribonucleoprotein that synthesizes TTAGGG repeats
4. Telomerase, cell immortality, and cancer
5. The RNA component of human telomerase
6. TLP1: A gene encoding a protein component of mammalian telomerase is a novel member of WD repeats family
7. A mammalian telomerase-associated protein
8. Telomerase catalytic subunit homologs from fission yeast and human
9. hEST2, the putative human telomerase catalytic subunit gene, is up-regulated in tumor cells and during immortalization
10. Specific association of human telomerase activity with immortal cells and cancer
11. A survey of telomerase acitivity in human cancer
12. Telomerase activity in pancreatic juice differentiates ductal carcinoma from adenoma and pancreatitis
13. Telomerase elevation in pancreatic ductal carcinoma compared to nonmalignant pathological states
14. Telomerase activity is detected in pancreatic cancer but not in benign tumors
15. Dissociation among in vitro telomerase activity, telomere maintenance, and cellular immortalization
16. Extension of life-span by introduction of telomerase into normal human cells
17. Reconstitution of telomerase activity in normal human cells leads to elongation of telomeres and extended replicative life span
18. Creation of human tumour cells with defined genetic elements
19. Human breast cancer cells generated by oncogenic transformation of primary mammary epithelial cells
20. Inhibition of human telomerase by a retrovirus expressing telomeric antisense RNA
21. Antisense telomerase treatment: Induction of two distinct pathways, apoptosis and differentiation
22. Targeted therapy of human malignant glioma in a mouse model by 2-5A antisense directed against telomerase RNA
23. Treatment of prostate cancer in vitro and in vivo with 2-5A-anti-telomerase RNA component
24. Inhibition of telomerase limits the growth of human cancer cells
25. Inhibition of human telomerase in immortal human cells leads to progressive telomere shortening and cell death
26. Ribozyme cleavage of telomerase mRNA sensitizes breast epithelial cells to inhibitors of topoisomerase
27. Inhibition of cell growth and telomerase activity of breast cancer cells in vitro by 3′-azido-3′-deoxythymidine
28. Inhibition of telomerase activity and cell proliferation by a reverse transcriptase inhibitor in gynaecological cancer cell lines
29. Inhibition of human telomerase by 2′-O-methyl-RNA
30. Telomerase inhibition by peptide nucleic acids reverses 'immortality' of transformed human cells
31. Telomere shortening and apoptosis in telomerase-inhibited human tumor cells
32. Attenuation of telomerase activity by a hammerhead ribozyme targeting the template region of telomerase RNA in endometrial carcinoma cells
33. Frequent amplification of the telomerase reverse transcriptase gene in human tumors
34. Cloning of human telomerase catalytic subunit (hTERT) gene promoter and identification of proximal core promoter sequences essential for transcriptional activation in immortalized and cancer cells
35. Cloning and characterization of the promoter region of human telomerase reverse transcriptase gene
36. Telomerase reverse transcriptase gene is a direct target of c-Myc but is not functionally equivalent in cellular transformation
37. Direct activation of TERT transcription by c-MYC
38. Myc activates telomerase
39. Telomerase activation by the E6 gene product of human papillomavirus type 16
40. Effect of oncogene expression on telomerase activation and telomere length in human endothelial, fibroblast and prostate epithelial cells
41. Bcl-2 modulates telomerase activity
42. Adenovirus-mediated p53 gene transduction inhibits telomerase activity independent of its effects on cell cycle arrest and apoptosis in human pancreatic cancer cells
43. Downregulation of telomerase reverse transcriptase mRNA expression by wild type p53 in human tumor cells
44. Molecular interactions between telomerase and the tumor suppressor protein p53 in vitro
45. Growth arrest of immortalized human keratinocytes and suppression of telomerase activity by p21WAF1 gene expression
46. Reexpression of the retinoblastoma protein in tumor cells induces senescence and telomerase inhibition
47. Microcell-mediated transfer of chromosome 4 into HeLa cells suppresses telomerase activity
48. Telomerase repressor sequences on chromosome 3 and induction of permanent growth arrest in human breast cancer cells
49. Repression of the telomerase catalytic subunit by a gene on human chromosome 3 that induces cellular senescence
50. Restoration of the cellular senescence program and repression of telomerase by human chromosome 3
51. Evidence for a putative telomerase repressor gene in the 3p14.2-p21.1 region
52. Telomerase activity correlates with histo-pathological factors in uterine endometrial carcinoma
53. Quantification of telomerase activity in sporadic colorectal carcinoma: Association with tumor growth and venous invasion
54. Telomerase activity and lymphovascular invasion in breast cancer
55. Correlation between telomerase activity and DNA ploidy in gastric cancer
56. High telomerase reverse transcriptase (hTERT) messenger RNA level correlates with tumor recurrence in patients with favorable histology Wilms' tumor
57. Telomerase activity in gastric cancer
58. Correlating telomerase activity levels with human neuroblastoma outcomes
59. Telomerase activity and survival of patients with node-positive breast cancer
60. Telomerase activity as a prognostic indicator in stage I non-small cell lung cancer
61. Prognostic impact of telomerase activity in non-small cell lung cancers
62. Telomere length and telomerase activity predict survival in patients with B cell chronic lymphocytic leukemia
63. Analysis of telomerase activity levels in breast cancer: Positive detection at the in situ breast carcinoma stage
64. Telomerase activity of cultured human pancreatic carcinoma cell lines correlates with their potential for migration and invasion
65. Effects of reverse transcriptase inhibitors on telomere length and telomerase activity in two immortalized human cell lines
66. Inhibition of human telomerase activity by peptide nucleic acids
67. Inhibition of human telomerase by a G-quadruplex-interactive compound
68. NMR-Based model of a telomerase-inhibiting compound bound to G-quadruplex DNA
69. A low threshold level of expression of mutant-template telomerase RNA inhibits human tumor cell proliferation
70. Anti-apoptotic role of telomerase in pheochromocytoma cells
71. Resistance to apoptosis in human cells conferred by telomerase function and telomere stability
72. Decline in telomerase activity as a measure of tumor cell killing by antineoplastic agents in vitro
73. Inhibition of telomerase activity by cisplatin in human testicular cancer cells
74. Down-regulation of telomerase activity in malignant lymphomas by radiation and chemotherapeutic agents
75. Suppression of telomerase activity as an indicator of drug-induced cytotoxicity against cancer cells: In vitro studies with fresh human tumor samples
76. Up-regulation of telomerase activity in human pancreatic cancer cells after exposure to etoposide
77. Inhibition of telomerase increases the susceptibility of human malignant glioblastoma cells to cisplatin-induced apoptosis
78. Attenuation of telomerase activity does not increase sensitivity of human melanoma cells to anticancer agents
79. Evidence for an alternative mechanism for maintaining telomere length in human tumors and tumor-derived cell lines